These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7927489)

  • 1. T lymphocytes and mast cells express messenger RNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
    Ying S; Durham SR; Jacobson MR; Rak S; Masuyama K; Lowhagen O; Kay AB; Hamid QA
    Immunology; 1994 Jun; 82(2):200-6. PubMed ID: 7927489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis.
    Ying S; Durham SR; Barkans J; Masuyama K; Jacobson M; Rak S; Löwhagen O; Moqbel R; Kay AB; Hamid QA
    Am J Respir Cell Mol Biol; 1993 Oct; 9(4):356-60. PubMed ID: 8398174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
    Masuyama K; Jacobson MR; Rak S; Meng Q; Sudderick RM; Kay AB; Lowhagen O; Hamid Q; Durham SR
    Immunology; 1994 Jun; 82(2):192-9. PubMed ID: 7927488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy.
    Ghaffar O; Laberge S; Jacobson MR; Lowhagen O; Rak S; Durham SR; Hamid Q
    Am J Respir Cell Mol Biol; 1997 Jul; 17(1):17-24. PubMed ID: 9224205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy.
    Nouri-Aria KT; Pilette C; Jacobson MR; Watanabe H; Durham SR
    J Allergy Clin Immunol; 2005 Jul; 116(1):73-9. PubMed ID: 15990777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season.
    Wilson DR; Nouri-Aria KT; Walker SM; Pajno GB; O'Brien F; Jacobson MR; Mackay IS; Durham SR
    J Allergy Clin Immunol; 2001 Jun; 107(6):971-6. PubMed ID: 11398073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects.
    Ying S; Meng Q; Barata LT; Robinson DS; Durham SR; Kay AB
    J Immunol; 1997 May; 158(10):5050-7. PubMed ID: 9144526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia.
    Durham SR; Ying S; Varney VA; Jacobson MR; Sudderick RM; Mackay IS; Kay AB; Hamid QA
    J Immunol; 1992 Apr; 148(8):2390-4. PubMed ID: 1560199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation.
    KleinJan A; McEuen AR; Dijkstra MD; Buckley MG; Walls AF; Fokkens WJ
    J Allergy Clin Immunol; 2000 Oct; 106(4):677-86. PubMed ID: 11031338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation.
    Bradding P; Feather IH; Wilson S; Bardin PG; Heusser CH; Holgate ST; Howarth PH
    J Immunol; 1993 Oct; 151(7):3853-65. PubMed ID: 8376806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
    J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine expression during allergen-induced late nasal responses: IL-4 and IL-5 mRNA is expressed early (at 6 h) predominantly by eosinophils.
    Nouri-Aria KT; O'Brien F; Noble W; Jabcobson MR; Rajakulasingam K; Durham SR
    Clin Exp Allergy; 2000 Dec; 30(12):1709-16. PubMed ID: 11122208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics.
    Ying S; Humbert M; Barkans J; Corrigan CJ; Pfister R; Menz G; Larché M; Robinson DS; Durham SR; Kay AB
    J Immunol; 1997 Apr; 158(7):3539-44. PubMed ID: 9120316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.
    Varney VA; Hamid QA; Gaga M; Ying S; Jacobson M; Frew AJ; Kay AB; Durham SR
    J Clin Invest; 1993 Aug; 92(2):644-51. PubMed ID: 8349803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis.
    Rondón C; Fernández J; López S; Campo P; Doña I; Torres MJ; Mayorga C; Blanca M
    J Allergy Clin Immunol; 2009 Nov; 124(5):1005-11.e1. PubMed ID: 19796796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated T cells in the nasal mucosa of patients with grass-pollen allergy. A pilot study.
    Hellquist HB; Karlsson MG; Rudblad S; Ekedahl C; Davidsson A
    Rhinology; 1992 Mar; 30(1):57-63. PubMed ID: 1579813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils, and neutrophils.
    Varney VA; Jacobson MR; Sudderick RM; Robinson DS; Irani AM; Schwartz LB; Mackay IS; Kay AB; Durham SR
    Am Rev Respir Dis; 1992 Jul; 146(1):170-6. PubMed ID: 1626799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo expression of signal transducer and activator of transcription factor 6 (STAT6) in nasal mucosa from atopic allergic rhinitis: effect of topical corticosteroids.
    Ghaffar O; Christodoulopoulos P; Lamkhioued B; Wright E; Ihaku D; Nakamura Y; Frenkiel S; Hamid Q
    Clin Exp Allergy; 2000 Jan; 30(1):86-93. PubMed ID: 10606935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.
    Tulic MK; Fiset PO; Christodoulopoulos P; Vaillancourt P; Desrosiers M; Lavigne F; Eiden J; Hamid Q
    J Allergy Clin Immunol; 2004 Feb; 113(2):235-41. PubMed ID: 14767435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.